Stay updated on AK104 with Chemotherapy in First-line ESCC Clinical Trial
Sign up to get notified when there's something new on the AK104 with Chemotherapy in First-line ESCC Clinical Trial page.

Latest updates to the AK104 with Chemotherapy in First-line ESCC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe history now shows a new revision entry (v3.4.2) and the previous funding/operating-status notice (v3.4.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check21 days agoChange DetectedA government funding lapse notice was added to the top of the page, and the record version was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check28 days agoChange DetectedThe Record History page now displays a glossary toggle, adds color-coded visual distinctions for additions (green) and deletions (red), and shows updated revision information (v3.4.0) while removing No FEAR Act data and updating from revision 3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check42 days agoChange DetectedA new revision entry, Revision: v3.3.4, was added to the Record History, replacing the previous Revision: v3.3.3 entry.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.3.3 was added and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedThe record history now includes a new revision entry v3.3.2 and removes the v3.2.0 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to AK104 with Chemotherapy in First-line ESCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 with Chemotherapy in First-line ESCC Clinical Trial page.